<?xml version="1.0" encoding="UTF-8" ?>
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</dc:title>
<dc:creator>Melgarejo, E.</dc:creator>
<dc:creator>Escribano, Luis</dc:creator>
<dc:creator>Orfao, Alberto</dc:creator>
<dc:description>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</dc:description>
<dc:description>This work was supported by PI05–0327, the Spanish Network of Mastocytosis and CIBERER (MSC, Spain), Ramón-Areces Foundation, grants SAF2005–01812 (MEC, Spain), grants CVI-657 and CVI-267 (Andalusian Research Program, PAI, Andalusia, Spain) to, F.S.J. and Fondo de Investigaciones Sanitarias (FIS, MSC, Spain) (06/0529) and Fundación MMA, Spain to, L.E.</dc:description>
<dc:description>Peer Reviewed</dc:description>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:date>2007</dc:date>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:type>artículo</dc:type>
<dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
<dc:identifier>doi: 10.1007/s00018-007-7331-4</dc:identifier>
<dc:identifier>issn: 1420-682X</dc:identifier>
<dc:identifier>e-issn: 1420-9071</dc:identifier>
<dc:identifier>Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/60188</dc:identifier>
<dc:identifier>10.1007/s00018-007-7331-4</dc:identifier>
<dc:language>en</dc:language>
<dc:rights>none</dc:rights>
<dc:publisher>Springer</dc:publisher>
</oai_dc:dc>
<?xml version="1.0" encoding="UTF-8" ?>
<resource>
<identifier>http://hdl.handle.net/10261/60188</identifier>
<alternateIdentifiers>
<alternateIdentifier identifierType="DOI">10.1007/s00018-007-7331-4</alternateIdentifier>
<alternateIdentifier alternateIdentifierType="DCSIC">62870</alternateIdentifier>
</alternateIdentifiers>
<titles>
<title lang="none">(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</title>
</titles>
<publisher>Springer</publisher>
<publicationYear>2007</publicationYear>
<resourceType resourceTypeGeneral="JournalArticle">artículo</resourceType>
<creators>
<creator>
<creatorName>Melgarejo, E.</creatorName>
</creator>
<creator>
<creatorName>Escribano, Luis</creatorName>
</creator>
<creator>
<creatorName>Orfao, Alberto</creatorName>
<nameIdentifier nameIdentifierScheme="DSPACE_CRIS_RP">rp08243</nameIdentifier>
</creator>
</creators>
<dates>
<date dateType="Issued">2007</date>
</dates>
<descriptions>
<description descriptionType="Abstract">Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</description>
</descriptions>
<rightsList>
</rightsList>
<relatedItems>
<relatedItem relationType="IsPublishedIn">
<titles>
<title>Cellular and Molecular Life Sciences 64(19-20)</title>
</titles>
<publicationYear>2007</publicationYear>
<firstPage>2690</firstPage>
<lastPage>2701</lastPage>
</relatedItem>
</relatedItems>
</resource>
<?xml version="1.0" encoding="UTF-8" ?>
<d:DIDL schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2012-11-14T10:25:21Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10261_60188">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10261/60188</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</dc:title>
<dc:creator>Melgarejo, E.</dc:creator>
<dc:creator>Escribano, Luis</dc:creator>
<dc:creator>Orfao, Alberto</dc:creator>
<dc:description>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</dc:description>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:date>2007</dc:date>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:type>artículo</dc:type>
<dc:identifier>Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/60188</dc:identifier>
<dc:identifier>10.1007/s00018-007-7331-4</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>closedAccess</dc:rights>
<dc:publisher>Springer</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10261_60188_1">
</d:Component>
</d:Item>
</d:DIDL>
<?xml version="1.0" encoding="UTF-8" ?>
<dim:dim schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field element="contributor" mdschema="dc" qualifier="author">Melgarejo, E.</dim:field>
<dim:field element="contributor" mdschema="dc" qualifier="author">Escribano, Luis</dim:field>
<dim:field authority="rp08243" confidence="600" element="contributor" mdschema="dc" qualifier="author">Orfao, Alberto</dim:field>
<dim:field element="date" mdschema="dc" qualifier="accessioned">2012-11-14T10:25:21Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="available">2012-11-14T10:25:21Z</dim:field>
<dim:field element="date" mdschema="dc" qualifier="issued">2007</dim:field>
<dim:field element="date" mdschema="dc" qualifier="updated">2012-11-14T10:25:21Z</dim:field>
<dim:field element="identifier" mdschema="dc">doi: 10.1007/s00018-007-7331-4</dim:field>
<dim:field element="identifier" mdschema="dc">issn: 1420-682X</dim:field>
<dim:field element="identifier" mdschema="dc">e-issn: 1420-9071</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="citation">Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="uri">http://hdl.handle.net/10261/60188</dim:field>
<dim:field element="identifier" mdschema="dc" qualifier="doi">10.1007/s00018-007-7331-4</dim:field>
<dim:field element="description" mdschema="dc" qualifier="abstract">Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</dim:field>
<dim:field element="description" mdschema="dc" qualifier="sponsorship">This work was supported by PI05–0327, the Spanish Network of Mastocytosis and CIBERER (MSC, Spain), Ramón-Areces Foundation, grants SAF2005–01812 (MEC, Spain), grants CVI-657 and CVI-267 (Andalusian Research Program, PAI, Andalusia, Spain) to, F.S.J. and Fondo de Investigaciones Sanitarias (FIS, MSC, Spain) (06/0529) and Fundación MMA, Spain to, L.E.</dim:field>
<dim:field element="description" mdschema="dc" qualifier="version">Peer Reviewed</dim:field>
<dim:field element="language" mdschema="dc" qualifier="iso">eng</dim:field>
<dim:field element="publisher" mdschema="dc">Springer</dim:field>
<dim:field element="rights" mdschema="dc">closedAccess</dim:field>
<dim:field element="title" mdschema="dc">(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</dim:field>
<dim:field element="type" mdschema="dc">artículo</dim:field>
<dim:field authority="" confidence="-1" element="type" lang="es_ES" mdschema="dc" qualifier="coar">http://purl.org/coar/resource_type/c_6501</dim:field>
</dim:dim>
<?xml version="1.0" encoding="UTF-8" ?>
<thesis schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd">
<title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</title>
<creator>Melgarejo, E.</creator>
<creator>Escribano, Luis</creator>
<creator>Orfao, Alberto</creator>
<description>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</description>
<date>2012-11-14</date>
<date>2012-11-14</date>
<date>2007</date>
<date>2012-11-14</date>
<type>artículo</type>
<identifier>Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</identifier>
<identifier>http://hdl.handle.net/10261/60188</identifier>
<identifier>10.1007/s00018-007-7331-4</identifier>
<language>eng</language>
<rights>closedAccess</rights>
<publisher>Springer</publisher>
</thesis>
<?xml version="1.0" encoding="UTF-8" ?>
<record schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield ind1=" " ind2=" " tag="042">
<subfield code="a">dc</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Melgarejo, E.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Escribano, Luis</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="720">
<subfield code="a">Orfao, Alberto</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="260">
<subfield code="c">2007</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="520">
<subfield code="a">Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">http://hdl.handle.net/10261/60188</subfield>
</datafield>
<datafield ind1="8" ind2=" " tag="024">
<subfield code="a">10.1007/s00018-007-7331-4</subfield>
</datafield>
<datafield ind1="0" ind2="0" tag="245">
<subfield code="a">(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</subfield>
</datafield>
</record>
<?xml version="1.0" encoding="UTF-8" ?>
<mets ID=" DSpace_ITEM_10261-60188" OBJID=" hdl:10261/60188" PROFILE="DSpace METS SIP Profile 1.0" TYPE="DSpace ITEM" schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd">
<metsHdr CREATEDATE="2022-08-19T11:22:21Z">
<agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
<name>DIGITAL.CSIC</name>
</agent>
</metsHdr>
<dmdSec ID="DMD_10261_60188">
<mdWrap MDTYPE="MODS">
<xmlData schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Melgarejo, E.</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Escribano, Luis</mods:namePart>
</mods:name>
<mods:name>
<mods:role>
<mods:roleTerm type="text">author</mods:roleTerm>
</mods:role>
<mods:namePart>Orfao, Alberto</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2012-11-14T10:25:21Z</mods:dateAccessioned>
</mods:extension>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2012-11-14T10:25:21Z</mods:dateAvailable>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2007</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10261/60188</mods:identifier>
<mods:identifier type="doi">10.1007/s00018-007-7331-4</mods:identifier>
<mods:abstract>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</mods:abstract>
<mods:language>
<mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">closedAccess</mods:accessCondition>
<mods:titleInfo>
<mods:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</mods:title>
</mods:titleInfo>
<mods:genre>artículo</mods:genre>
</mods:mods>
</xmlData>
</mdWrap>
</dmdSec>
<amdSec ID="TMD_10261_60188">
<rightsMD ID="RIG_10261_60188">
<mdWrap MDTYPE="OTHER" MIMETYPE="text/plain" OTHERMDTYPE="DSpaceDepositLicense">
<binData>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</binData>
</mdWrap>
</rightsMD>
</amdSec>
<amdSec ID="FO_10261_60188_1">
<techMD ID="TECH_O_10261_60188_1">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>https://digital.csic.es/bitstream/10261/60188/1/accesoRestringido.pdf</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>42637ae8545636bc41605c1740a9a84e</premis:messageDigest>
</premis:fixity>
<premis:size>15753</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>application/pdf</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>accesoRestringido.pdf</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<amdSec ID="FT_10261_60188_5">
<techMD ID="TECH_T_10261_60188_5">
<mdWrap MDTYPE="PREMIS">
<xmlData schemaLocation="http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd">
<premis:premis>
<premis:object>
<premis:objectIdentifier>
<premis:objectIdentifierType>URL</premis:objectIdentifierType>
<premis:objectIdentifierValue>https://digital.csic.es/bitstream/10261/60188/5/accesoRestringido.pdf.txt</premis:objectIdentifierValue>
</premis:objectIdentifier>
<premis:objectCategory>File</premis:objectCategory>
<premis:objectCharacteristics>
<premis:fixity>
<premis:messageDigestAlgorithm>MD5</premis:messageDigestAlgorithm>
<premis:messageDigest>7c821e3180e847b607957fd9795236ad</premis:messageDigest>
</premis:fixity>
<premis:size>401</premis:size>
<premis:format>
<premis:formatDesignation>
<premis:formatName>text/plain</premis:formatName>
</premis:formatDesignation>
</premis:format>
</premis:objectCharacteristics>
<premis:originalName>accesoRestringido.pdf.txt</premis:originalName>
</premis:object>
</premis:premis>
</xmlData>
</mdWrap>
</techMD>
</amdSec>
<fileSec>
<fileGrp USE="ORIGINAL">
<file ADMID="FO_10261_60188_1" CHECKSUM="42637ae8545636bc41605c1740a9a84e" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10261_60188_1" ID="BITSTREAM_ORIGINAL_10261_60188_1" MIMETYPE="application/pdf" SEQ="1" SIZE="15753">
</file>
</fileGrp>
<fileGrp USE="TEXT">
<file ADMID="FT_10261_60188_5" CHECKSUM="7c821e3180e847b607957fd9795236ad" CHECKSUMTYPE="MD5" GROUPID="GROUP_BITSTREAM_10261_60188_5" ID="BITSTREAM_TEXT_10261_60188_5" MIMETYPE="text/plain" SEQ="5" SIZE="401">
</file>
</fileGrp>
</fileSec>
<structMap LABEL="DSpace Object" TYPE="LOGICAL">
<div ADMID="DMD_10261_60188" TYPE="DSpace Object Contents">
<div TYPE="DSpace BITSTREAM">
</div>
</div>
</structMap>
</mets>
<?xml version="1.0" encoding="UTF-8" ?>
<mods:mods schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Melgarejo, E.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Escribano, Luis</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Orfao, Alberto</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2012-11-14T10:25:21Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2012-11-14T10:25:21Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2007</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</mods:identifier>
<mods:identifier type="uri">http://hdl.handle.net/10261/60188</mods:identifier>
<mods:identifier type="doi">10.1007/s00018-007-7331-4</mods:identifier>
<mods:abstract>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</mods:abstract>
<mods:language>
<mods:languageTerm>eng</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">closedAccess</mods:accessCondition>
<mods:titleInfo>
<mods:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</mods:title>
</mods:titleInfo>
<mods:genre>artículo</mods:genre>
</mods:mods>
<?xml version="1.0" encoding="UTF-8" ?>
<oai_cerif:Publication id="10261/60188">
<oai_cerif:Type>http://purl.org/coar/resource_type/c_18cf</oai_cerif:Type>
<oai_cerif:Title lang="en">(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</oai_cerif:Title>
<oai_cerif:PublicationDate>2007</oai_cerif:PublicationDate>
<oai_cerif:DOI>10.1007/s00018-007-7331-4</oai_cerif:DOI>
<oai_cerif:Handle>10261/60188</oai_cerif:Handle>
<oai_cerif:URN>http://hdl.handle.net/10261/60188</oai_cerif:URN>
<oai_cerif:Authors>
<oai_cerif:Author>
<oai_cerif:DisplayName>Melgarejo, E.</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Escribano, Luis</oai_cerif:DisplayName>
</oai_cerif:Author>
<oai_cerif:Author>
<oai_cerif:DisplayName>Orfao, Alberto</oai_cerif:DisplayName>
<oai_cerif:Person id="4c136758-7ca2-4c99-9887-cc84905b462c">
<oai_cerif:PersonName>
<oai_cerif:FamilyNames>Orfao</oai_cerif:FamilyNames>
<oai_cerif:FirstNames>Alberto</oai_cerif:FirstNames>
</oai_cerif:PersonName>
</oai_cerif:Person>
</oai_cerif:Author>
</oai_cerif:Authors>
<oai_cerif:Publishers>
<oai_cerif:Publisher>
<oai_cerif:DisplayName>Springer</oai_cerif:DisplayName>
</oai_cerif:Publisher>
</oai_cerif:Publishers>
<oai_cerif:Abstract lang="en">Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</oai_cerif:Abstract>
<ns4:Access>http://purl.org/coar/access_right/c_14cb</ns4:Access>
</oai_cerif:Publication>
<?xml version="1.0" encoding="UTF-8" ?>
<atom:entry schemaLocation="http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml">
<atom:id>http://hdl.handle.net/10261/60188/ore.xml</atom:id>
<atom:published>2012-11-14T10:25:21Z</atom:published>
<atom:updated>2012-11-14T10:25:21Z</atom:updated>
<atom:source>
<atom:generator>DIGITAL.CSIC</atom:generator>
</atom:source>
<atom:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</atom:title>
<atom:author>
<atom:name>Melgarejo, E.</atom:name>
</atom:author>
<atom:author>
<atom:name>Escribano, Luis</atom:name>
</atom:author>
<atom:author>
<atom:name>Orfao, Alberto</atom:name>
</atom:author>
<oreatom:triples>
<rdf:Description about="http://hdl.handle.net/10261/60188/ore.xml#atom">
<dcterms:modified>2012-11-14T10:25:21Z</dcterms:modified>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/60188/1/accesoRestringido.pdf">
<dcterms:description>ORIGINAL</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/60188/2/license.txt">
<dcterms:description>LICENSE</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/60188/3/82297.zip">
<dcterms:description>SWORD</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/60188/4/accesoRestringido.pdf.jpg">
<dcterms:description>THUMBNAIL</dcterms:description>
</rdf:Description>
<rdf:Description about="https://digital.csic.es/bitstream/10261/60188/5/accesoRestringido.pdf.txt">
<dcterms:description>TEXT</dcterms:description>
</rdf:Description>
</oreatom:triples>
</atom:entry>
<?xml version="1.0" encoding="UTF-8" ?>
<qdc:qualifieddc schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
<dc:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</dc:title>
<dc:creator>Melgarejo, E.</dc:creator>
<dc:creator>Escribano, Luis</dc:creator>
<dc:creator>Orfao, Alberto</dc:creator>
<dcterms:abstract>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</dcterms:abstract>
<dcterms:dateAccepted>2012-11-14T10:25:21Z</dcterms:dateAccepted>
<dcterms:available>2012-11-14T10:25:21Z</dcterms:available>
<dcterms:created>2012-11-14T10:25:21Z</dcterms:created>
<dcterms:issued>2007</dcterms:issued>
<dc:type>artículo</dc:type>
<dc:identifier>Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/60188</dc:identifier>
<dc:identifier>10.1007/s00018-007-7331-4</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>closedAccess</dc:rights>
<dc:publisher>Springer</dc:publisher>
</qdc:qualifieddc>
<?xml version="1.0" encoding="UTF-8" ?>
<rdf:RDF schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
<ow:Publication about="oai:digital.csic.es:10261/60188">
<dc:title>(-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes</dc:title>
<dc:creator>Melgarejo, E.</dc:creator>
<dc:creator>Escribano, Luis</dc:creator>
<dc:creator>Orfao, Alberto</dc:creator>
<dc:description>Mast cells are multipotent effector cells of the immune system. They are able to induce and enhance angiogenesis via multiple pathways. (-)-Epigallocatechin-3-gallate (EGCG), a major component of green tea and a putative chemopreventive agent, was reported to inhibit tumor invasion and angiogenesis, processes that are essential for tumor growth and metastasis. Using the human mast cell line HMC-1 and commercial cDNA macroarrays, we evaluated the effect of EGCG on the expression of angiogenesis-related genes. Our data show that among other effects, EGCG treatment reduces expression of two integrins (α5 and β3) and a chemokine (MCP1), resulting in a lower adhesion of mast cells associated with a decreased potential to produce signals eliciting monocyte recruitment. These effects on gene expression levels are functionally validated by showing inhibitory effects in adhesion, aggregation, migration and recruitment assays. © 2007 Birkhäuser Verlag.</dc:description>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:date>2007</dc:date>
<dc:date>2012-11-14T10:25:21Z</dc:date>
<dc:type>artículo</dc:type>
<dc:identifier>Cellular and Molecular Life Sciences 64(19-20): 2690-2701 (2007)</dc:identifier>
<dc:identifier>http://hdl.handle.net/10261/60188</dc:identifier>
<dc:identifier>10.1007/s00018-007-7331-4</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>closedAccess</dc:rights>
<dc:publisher>Springer</dc:publisher>
</ow:Publication>
</rdf:RDF>